Validation of high-performance liquid chromatographic-mass spectrometric method for the analysis of lidocaine in human plasma

Journal of Chromatographic Science

Volumn 44, Issue 5, 2006, Pages 262-265

  Chik, Z ^a   Lee, T D ^b   Holt, D W ^b   Johnston, A ^a   Tucker, A T ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750246010     PISSN: 00219665     EISSN: 00219665     Source Type: Journal    
DOI: 10.1093/chromsci/44.5.262     Document Type: Article

References (8)

1. D. Lalka, R.K. Griffith, and C.L. Cronenberger. The hepatic first-pass metabolism of problematic drugs. J. Clin. Pharmacol. 33(7): 657-69 (1993).
2. A. Somogyi, M. Eichelbaum, and R. Gugler. Prediction of bioavailability for drugs with a high first-pass effect using oral clearance data. Eur. J. Clin. Pharmacol. 22(1): 85-90 (1982).
3. H.A. Adams, J. Biscoping, K. Ludolf, A. Borgmann, M. Bachmann, and G. Hempelmann. The quantitative analysis of amide local anesthetics using high pressure liquid chromatography and ultraviolet detection (HPLC/UV). Reg. Anaesth. 12(3): 53-57 (1989).
4. Y. Chen, J.M. Potter, and P.J. Ravenscroft. A quick, sensitive high-performance liquid chromatography assay for monoethylglycinexylidide and lignocaine in serum/plasma using solid-phase extraction. Ther. Drug Monit. 14(4): 317-21 (1992).
5. L.D. Bo, P. Mazzucchelli, and A. Marzo. Highly sensitive bioassay of lidocaine in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 854(1-2): 3-11 (1999).
6. M. Abdel-Rehim, M. Bielenstein, Y. Askemark, N. Tyrefors, and T. Arvidsson. High-performance liquid chromatography-tandem electrospray mass spectrometry for the determination of lidocaine and its metabolites in human plasma and urine. J. Chromatogr. B Biomed. Sci. Appl. 741(2): 175-88 (2000).
7. T. Watanabe, A. Namera, M. Yashiki, Y. Iwasaki, and T. Kojima. Simple analysis of local anaesthetics in human blood using headspace solid-phase microextraction and gas chromatography-mass spectrometry-electron impact ionization selected ion monitoring. J. Chromatogr. B Biomed. Sci. Appl. 709(2): 225-32 (1998).
8. United States Food and Drug Administration. Guidance For Industry: Bioanalytical Method Validation. US FDA, Washington, D.C., 2001. http://www.fda.gov/CDER/GUIDANCE/4252fnl.htm. (April 5, 2005).